Literature DB >> 9408553

Risk of suicide attempts after benzodiazepine and/or antidepressant use.

C I Neutel1, S B Patten.   

Abstract

PURPOSE: Recent publications imply the existence of associations between psychotropic drugs use and risk of suicide. Some studies have measured the tissue level of these drugs in suicide deaths, while others compared toxicity indices, defined as number of suicide deaths per million prescriptions for individual antidepressants. Few of these studies used unexposed controls. The objective of this cohort study was to evaluate suicide attempts in subjects recently exposed to benzodiazepines and/or antidepressants, as compared to unexposed controls.
METHODS: A population of 225,796 persons with prescriptions for benzodiazepines were selected from the Saskatchewan Health Data Bases. Controls consisted of 97,862 individuals who did not receive benzodiazepines.
RESULTS: Stratifying the populations into antidepressant users and non-antidepressant users indicated that nonantidepressant users had statistically significant associations between suicide attempts and benzodiazepine use (odds ratio (OR) = 6.2), antipsychotic use, (OR = 2.6), and a history of past treatment for drug/alcohol abuse (OR = 13.4). Antidepressant users showed a statistically significant relation only with past treatment for drug/alcohol use (OR = 5.8). It is argued that the large OR for antidepressant use is due to confounding by indication. If so, the concept of toxicity index is misleading and should not be used.
CONCLUSIONS: The association between benzodiazepine use and attempted suicide is especially high for nonantidepressant users, for the young, and for males. Whether this relationship is causal or not, physicians should be aware of the high potential for suicide attempts when prescribing benzodiazepines for patients in these high risk groups.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9408553     DOI: 10.1016/s1047-2797(97)00126-9

Source DB:  PubMed          Journal:  Ann Epidemiol        ISSN: 1047-2797            Impact factor:   3.797


  18 in total

1.  Benzodiazepine therapy in psychiatric outpatients is associated with deliberate self-poisoning events at emergency departments-a population-based nested case-control study.

Authors:  Hsin-I Shih; Ming-Chia Lin; Che-Chen Lin; Hsiang-Chin Hsu; Hsin-Ling Lee; Chih-Hsien Chi; Fung-Chang Sung; Yen-Jung Chang; Chia-Hung Kao
Journal:  Psychopharmacology (Berl)       Date:  2013-05-09       Impact factor: 4.530

Review 2.  Benzodiazepine Use, Misuse, and Harm at the Population Level in Canada: A Comprehensive Narrative Review of Data and Developments Since 1995.

Authors:  Yoko Murphy; Emily Wilson; Elliot M Goldner; Benedikt Fischer
Journal:  Clin Drug Investig       Date:  2016-07       Impact factor: 2.859

3.  Road traffic accidents and psychotropic medication use in The Netherlands: a case-control study.

Authors:  Silvia Ravera; Nienke van Rein; Johan J de Gier; Lolkje T W de Jong-van den Berg
Journal:  Br J Clin Pharmacol       Date:  2011-09       Impact factor: 4.335

4.  Concurrent use of benzodiazepines, antidepressants, and opioid analgesics with zolpidem and risk for suicide: a case-control and case-crossover study.

Authors:  Hi Gin Sung; Junquing Li; Jin Hyun Nam; Dae Yeon Won; BongKyoo Choi; Ju-Young Shin
Journal:  Soc Psychiatry Psychiatr Epidemiol       Date:  2019-04-29       Impact factor: 4.328

Review 5.  Hypnotic Medications and Suicide: Risk, Mechanisms, Mitigation, and the FDA.

Authors:  W Vaughn McCall; Ruth M Benca; Peter B Rosenquist; Mary Anne Riley; Laryssa McCloud; Jill C Newman; Doug Case; Meredith Rumble; Andrew D Krystal
Journal:  Am J Psychiatry       Date:  2016-09-09       Impact factor: 18.112

6.  The effects of diazepam on human self-aggressive behavior.

Authors:  Mitchell E Berman; Gabriele D Jones; Michael S McCloskey
Journal:  Psychopharmacology (Berl)       Date:  2004-08-17       Impact factor: 4.530

7.  Risk of preterm delivery and other adverse perinatal outcomes in relation to maternal use of psychotropic medications during pregnancy.

Authors:  Ronit Calderon-Margalit; Chunfang Qiu; Asher Ornoy; David S Siscovick; Michelle A Williams
Journal:  Am J Obstet Gynecol       Date:  2009-08-18       Impact factor: 8.661

8.  Predictors of spontaneous and systematically assessed suicidal adverse events in the treatment of SSRI-resistant depression in adolescents (TORDIA) study.

Authors:  David A Brent; Graham J Emslie; Greg N Clarke; Joan Asarnow; Anthony Spirito; Louise Ritz; Benedetto Vitiello; Satish Iyengar; Boris Birmaher; Neal D Ryan; Jamie Zelazny; Matthew Onorato; Betsy Kennard; Taryn L Mayes; Lynn L Debar; James T McCracken; Michael Strober; Robert Suddath; Henrietta Leonard; Giovanna Porta; Martin B Keller
Journal:  Am J Psychiatry       Date:  2009-02-17       Impact factor: 18.112

9.  Comorbid anxiety as a suicide risk factor among depressed veterans.

Authors:  Paul N Pfeiffer; Dara Ganoczy; Mark Ilgen; Kara Zivin; Marcia Valenstein
Journal:  Depress Anxiety       Date:  2009       Impact factor: 6.505

10.  Risks of Benzodiazepines in Chronic Obstructive Pulmonary Disease with Comorbid Posttraumatic Stress Disorder.

Authors:  Lucas M Donovan; Carol A Malte; Laura J Spece; Matthew F Griffith; Laura C Feemster; Ruth A Engelberg; David H Au; Eric J Hawkins
Journal:  Ann Am Thorac Soc       Date:  2019-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.